Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 21, 2006; 12(15): 2357-2362
Published online Apr 21, 2006. doi: 10.3748/wjg.v12.i15.2357
Published online Apr 21, 2006. doi: 10.3748/wjg.v12.i15.2357
Figure 1 Effect of IL-10 on liver histological change in group C at the 7th wk (A), group I at the 7th wk (B), group C at the 11th wk (C), group I at the 11th wk (D), and group N (E).
Figure 2 Desmin expression in freshly isolated HSCs(SP×100).
Figure 3 Expression of TGF-β1 in HSCs the first (A) and the second stage (B).
Figure 4 Expression of TGF-β1 protein in HSCs in group C (A) at the 7th wk, group I (B) at the 7th wk, group C at the 11th wk (C), and group I (D) at the 11th wk.
Figure 5 Expression of TGF-β1 in liver tissue in group N2 (A), group T (B), group R (C), and group M (D).
- Citation: Shi MN, Huang YH, Zheng WD, Zhang LJ, Chen ZX, Wang XZ. Relationship between transforming growth factor β1 and anti-fibrotic effect of interleukin-10. World J Gastroenterol 2006; 12(15): 2357-2362
- URL: https://www.wjgnet.com/1007-9327/full/v12/i15/2357.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i15.2357